Qianyu Hu

Qianyu Hu advises on a wide range of capital market transactions, primarily representing issuers and underwriters in initial public offerings. Qianyu also has experience in other equity offerings, such as private placings and rights issues, mergers and acquisitions and other general corporate law matters.

Prior to joining O’Melveny, Qianyu worked in the Hong Kong office of another international law firm.

• Beauty Farm Medical and Health Industry Inc. in its approximately US$100 million IPO and listing on the Hong Kong Stock Exchange
• 3D Medicines Inc. in its US$52 million IPO and listing on the Hong Kong Stock Exchange
• Gaush Meditech Ltd. in its US$86 million IPO and listing on the Hong Kong Stock Exchange
• Haitong International Capital Limited and CCB International Capital Limited as joint sponsors, and other underwriters in the IPO and listing of Huafang Group Inc. on the Hong Kong Stock Exchange
• ABCI Captial Limited, CICC Hong Kong Securities Limited and other underwriters in the H-share IPO of Lushang Life Services Co., Ltd (2376.HK) on the Hong Kong Stock Exchange
• Gushengtang Holdings Limited in its US$104 million IPO and listing on the Hong Kong Stock Exchange
• Goldman Sachs (Asia) L.L.C. and China International Capital Corporation Hong Kong Securities Limited and other underwriters in the US$145 million IPO and listing of Shanghai HeartCare Medical Technology Corporation Limited on the Hong Kong Stock Exchange
• CCB International Capital Limited as sole sponsor and other underwriters in the approximately US$85 million IPO and listing of Kangqiao Service Group Limited on the Hong Kong Stock Exchange
• BNP Paribas, China Construction Bank International, Industrial and Commercial Bank of China International and other underwriters in the spin-off and approximately US$126 million listing of Central China Management Company Limited on the Hong Kong Stock Exchange
• J.P. Morgan, BofA Securities, CICC and Haitong International as joint sponsors and other underwriters in the approximately US$1.67 billion secondary listing of GDS Holdings Limited on the Hong Kong Stock Exchange
• Simcere Pharmaceutical Group Limited in its US$461 million IPO and listing on the Hong Kong Stock Exchange
• Hygeia Healthcare Holdings Co., Limited in its US$286 million IPO and listing on the Hong Kong Stock Exchange
• Akeso Biopharma in its US$383 million IPO and listing on the Hong Kong Stock Exchange
• Guotai Junan Capital as sole sponsor and Guotai Junan Securities (Hong Kong) as main underwriter, and other underwriters in the US$65 million IPO and listing of Zhongguancun Science-Tech Leasing on the Hong Kong Stock Exchange
• Redsun Properties Group in its US$234 million initial public offering on the Main Board of the Hong Kong Stock Exchange
• Jiangxi Bank in its US$952 million initial public offering on the Main Board of the Hong Kong Stock Exchange
• CMBI, CCBI, Huatai, Guotai Junan and BOCI as underwriters in the US$761 million initial public offering of Bank of Gansu on the Main Board of the Hong Kong Stock Exchange
• Morgan Stanley, HSBC and Citi as underwriters in the US$491 million initial public offering of Crystal Group, a Hong Kong apparel manufacturer, on the Main Board of the Hong Kong Stock Exchange
• Morgan Stanley and CMBI as underwriters in the US$149 million initial public offering of Bestway Global, an outdoor leisure product manufacturer in China, on the Main Board of the Hong Kong Stock Exchange
• BAML, CICC, BOCI and CMS as underwriters in the US$102 million initial public offering of New Century Healthcare, a leading pediatric healthcare provider in China, on the Main Board of the Hong Kong Stock Exchange
• Morgan Stanley, Credit Suisse and CMS as underwriters in the US$322 million initial public offering of Zhou Hei Ya, a well-known braised food brand in China, on the Main Board of the Hong Kong Stock Exchange